Clinical Trial Update: Treatment With MSC in HIV-infected Patients With Controlled Viremia and Immunological Discordant Response [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating mesenchymal stromal cells (MSC) in HIV-infected individuals with controlled viremia but immunological discordant response; study stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Mesenchymal stromal cells

Snippet

Sponsor: Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | Conditions: Discordant Immunological Response in HIV Infected Subjects | Phase 1, Phase 2 | Status: COMPLETED